New drug BW-50218 begins first human safety tests
Knowledge-focused
Recruiting now
This early-phase trial is testing the safety and tolerability of a new drug called BW-50218 in 60 healthy adults. Participants receive a single injection of either the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is…
Phase: PHASE1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC